Elanix Biotechnologies AG (FRA:ELN) Gross Margin % : -446.88% (As of Dec. 2018)

Elanix Biotechnologies AG Gross Margin % Chart

Elanix Biotechnologies AG Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
Gross Margin %		Get a 7-Day Free Trial					-	-	50.00	37.44	-353.23

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
Gross Margin %	Get a 7-Day Free Trial															50.00	75.64	17.45	-256.67	-446.88

Competitive Comparison of Elanix Biotechnologies AG's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's Gross Margin % falls into.

Elanix Biotechnologies AG Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Elanix Biotechnologies AG's Gross Margin for the fiscal year that ended in Dec. 2018 is calculated as

Elanix Biotechnologies AG's Gross Margin for the quarter that ended in Dec. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Elanix Biotechnologies AG  (FRA:ELN) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Elanix Biotechnologies AG had a gross margin of -446.88% for the quarter that ended in Dec. 2018 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Elanix Biotechnologies AG Gross Margin % Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG (FRA:ELN) Business Description